Page last updated: 2024-11-08

2-aminoquinoxaline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-aminoquinoxaline: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID224573
CHEMBL ID5092101
SCHEMBL ID462847
MeSH IDM0356671

Synonyms (35)

Synonym
quinoxalin-2-amine
quinoxalin-2-yl-amine
nsc44679
nsc-44679
nsc-13155
nsc13155
5424-05-5
2-quinoxalinamine
2-aminoquinoxaline
AKOS009097806
bdbm92286
upa_1
quinoxalin-2-ylamine
FT-0600461
2-amino-quinoxaline
AM807091
MB00639
SCHEMBL462847
2-quinoxalinamine #
W-205983
mfcd00094018
DTXSID00279557
2-aminoquinoxaline, aldrichcpr
S11010
CCG-321211
AS-19969
doi:10.14272/yowaezwwqfsejd-uhfffaoysa-n.1
10.14272/YOWAEZWWQFSEJD-UHFFFAOYSA-N.2
10.14272/YOWAEZWWQFSEJD-UHFFFAOYSA-N.1
doi:10.14272/yowaezwwqfsejd-uhfffaoysa-n.2
CHEMBL5092101
CS-W022950
EN300-97442
SY076122
Z979455432
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID1810680Stabilization of human recombinant TLX LBD assessed as change in melting temperature at 500 uM by DSF assay2021Journal of medicinal chemistry, 06-24, Volume: 64, Issue:12
Propranolol Activates the Orphan Nuclear Receptor TLX to Counteract Proliferation and Migration of Glioblastoma Cells.
AID1810679Inverse agonist activity at full length TLX activating element expressed in human HEK293T cells coexpressing human full-length TLX/Gal4-VP 16 assessed as fold decrease in reporter activity at 100 uM by luciferase reporter gene assay relative to control2021Journal of medicinal chemistry, 06-24, Volume: 64, Issue:12
Propranolol Activates the Orphan Nuclear Receptor TLX to Counteract Proliferation and Migration of Glioblastoma Cells.
AID1810678Agonist activity at in human TLX LBD expressed in human HEK293T cells coexpressing Gal4-VP 16 assessed as fold decrease in reporter activity at 100 uM measured after 14 hrs by luciferase reporter gene assay relative to control2021Journal of medicinal chemistry, 06-24, Volume: 64, Issue:12
Propranolol Activates the Orphan Nuclear Receptor TLX to Counteract Proliferation and Migration of Glioblastoma Cells.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (33.33)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (50.00)24.3611
2020's1 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.37

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.37 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.37)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]